Related Experiment Video
Updated: May 29, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Rubella elimination, the Canadian experience.
Jeannette F Macey1, Theresa Tam, Tammy Lipskie
1Infectious Disease and Emergency Preparedness Branch, Public Health Agency of Canada, Ottawa. jeannette.macey@phac-aspc.gc.ca
Canada has interrupted indigenous rubella virus transmission through high vaccination rates. However, outbreaks can reoccur in communities with low vaccine coverage, highlighting the need for targeted surveillance and response.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Immunization Programs
Background:
- Rubella elimination requires interrupting endemic transmission and preventing reestablishment after importation.
- Canada implemented immunization strategies aiming for rubella virus elimination.
- Sustained high vaccine coverage is crucial for maintaining elimination.
Observation:
- Surveillance data confirmed interruption of indigenous rubella transmission in Canada.
- A 2005 rubella outbreak occurred following importation into an under-vaccinated community.
- This outbreak demonstrated the potential for reestablishing multiple transmission chains.
Findings:
- Indigenous rubella virus transmission has been interrupted.
- Low vaccine coverage pockets remain susceptible to imported rubella cases.
- No indigenous rubella circulation has been detected since the 2005 outbreak.
Implications:
- Maintaining high population immunity is essential to prevent rubella re-establishment.
- Targeted surveillance and rapid response are critical in vulnerable populations.
- Vigilance is necessary to mitigate risks associated with imported rubella cases.
More Related Videos
14:14Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR
Published on: December 6, 2014
09:14An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
Published on: January 26, 2019
Related Concept Videos
Vaccinations
Respiratory Syncytial Virus Disease
Smallpox
Poliomyelitis
Rocky Mountain Spotted Fever
Rh Blood Group